Literature DB >> 20941590

Peptides representing the specific variable regions but not the full porin proteins can be useful for antibody based diagnosis of typhoid fever.

S Kumar1, S Kapil, V Gautam, S K Verma, P Ray.   

Abstract

Antibody response to major porin proteins of S. Typhi (OmpC and OmpF) was evaluated in sera of typhoid patients (culture positive, n = 28; Widal positive, n = 16). Sera from fever patients (n = 6) having etiology other than Salmonella, and normal healthy human controls (n = 18) were also included. No significant difference between the anti-OmpC and anti-OmpF antibodies (Ab) of typhoid patients and controls was observed. The amino acid sequences of OmpC (and OmpF) porin of enterobacteria was aligned and searched for the variable regions specific to S. Typhi. Two regions, each representing one specific variable region of OmpC and OmpF, were selected (peptides for these regions were custom synthesized). The peptides were evaluated for Ab response of sera. A significantly higher level of Ab to both the peptides was observed in the sera of typhoid patients. The findings suggest that porins of S. Typhi are cross reactive and are not good markers for Ab-based diagnosis of typhoid fever, however, peptides representing the variable regions specific to S. Typhi may have greater diagnostic potential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20941590     DOI: 10.1007/s12223-010-0086-6

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  18 in total

1.  Serology of typhoid fever in an area of endemicity and its relevance to diagnosis.

Authors:  D House; J Wain; V A Ho; T S Diep; N T Chinh; P V Bay; H Vinh; M Duc; C M Parry; G Dougan; N J White; T T Hien; J J Farrar
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Reassessment of the Widal test in the diagnosis of typhoid.

Authors:  B Senewiratne; K Senewiratne
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Detection of Salmonella enterica serovar Typhi (S. Typhi) by selective amplification of invA, viaB, fliC-d and prt genes by polymerase chain reaction in mutiplex format.

Authors:  S Kumar; K Balakrishna; H V Batra
Journal:  Lett Appl Microbiol       Date:  2006-02       Impact factor: 2.858

4.  Active protection of mice against Salmonella typhi by immunization with strain-specific porins.

Authors:  A Isibasi; V Ortiz-Navarrete; J Paniagua; R Pelayo; C R González; J A García; J Kumate
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

5.  Expression of Salmonella typhi and Escherichia coli OmpC is influenced differently by medium osmolarity; dependence on Escherichia coli OmpR.

Authors:  J L Puente; A Verdugo-Rodríguez; E Calva
Journal:  Mol Microbiol       Date:  1991-05       Impact factor: 3.501

6.  Diagnosis of typhoid fever: detection of Salmonella typhi porins-specific antibodies by inhibition ELISA.

Authors:  K S Nandakumar; V Palanivel; V Muthukkaruppan
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

7.  Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever.

Authors:  R H Gilman; M Terminel; M M Levine; P Hernandez-Mendoza; R B Hornick
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

8.  Induction of systemic and mucosal immune response in mice immunised with porins of Salmonella typhi.

Authors:  Mantej Singh; Harpreet Vohra; Lata Kumar; Nirmal K Ganguly
Journal:  J Med Microbiol       Date:  1999-01       Impact factor: 2.472

9.  Diagnostic value of the Widal test in areas endemic for typhoid fever.

Authors:  M M Levine; O Grados; R H Gilman; W E Woodward; R Solis-Plaza; W Waldman
Journal:  Am J Trop Med Hyg       Date:  1978-07       Impact factor: 2.345

10.  Overexpression, purification, and immunogenicity of recombinant porin proteins of Salmonella enterica serovar Typhi (S. Typhi).

Authors:  Verma Shailendra Kumar; Vandana Gautam; Konduru Balakrishna; Subodh Kumar
Journal:  J Microbiol Biotechnol       Date:  2009-09       Impact factor: 2.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.